Abstract: The present invention relates to an elderberry extract for use in a method of preventing or treating a SARS-CoV-2 infection, wherein said elderberry extract is an ultrafiltrated elderberry extract. The present invention further relates to a composition, preferably pharmaceutical composition, comprising an elderberry extract. Furthermore, the present invention relates to a method of preparing an ultrafiltrated elderberry extract.

Abstract: A device for converting mechanical energy into electric energy. A first magnet is arranged above a second magnet and in a manner movable in the direction of the second magnet. The same poles of the first magnet and the second magnet are aligned with each other. A first coil has windings and an inner space formed by the windings. The first coil receives the first magnet in its inner space during a movement in the direction of the second magnet and generates a corresponding induction voltage. A second coil has windings and an inner space formed by the windings. The second coil is arranged below the first coil and aligned perpendicularly to the first coil. The second coil is arranged at least partially around the second magnet and generates a voltage when the first magnet moves in the direction of the second magnet.

Abstract: Prophylaxis or treatment of allergic airway inflammatory activity is described using Bifidobacterium longum NCIMB 41003. Also described is an exopolysaccharide which comprises the structure Formula (I). The polysaccharide may be used for treating or preventing undesirable inflammatory activity.